NEXGEL, Inc. – NASDAQ:NXGL
NEXGEL stock price today
$2.39
-2.31
-49.15%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
NEXGEL stock price monthly change
+117.59%
month
NEXGEL stock price quarterly change
+117.59%
quarter
NEXGEL stock price yearly change
+112.67%
year
NEXGEL key metrics
Market Cap | 31.71M |
Enterprise value | 8.70M |
P/E | -1.71 |
EV/Sales | 4.24 |
EV/EBITDA | -2.79 |
Price/Sales | 3.77 |
Price/Book | 1.01 |
PEG ratio | 0.17 |
EPS | -0.54 |
Revenue | 4.73M |
EBITDA | -3.15M |
Income | -3.19M |
Revenue Q/Q | 104.19% |
Revenue Y/Y | 108.35% |
Profit margin | -231.74% |
Oper. margin | -163.48% |
Gross margin | 12.5% |
EBIT margin | -163.48% |
EBITDA margin | -66.55% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNEXGEL stock price history
NEXGEL stock forecast
NEXGEL financial statements
| Jun 2023 | 1.16M | -695K | -59.55% |
|---|---|---|---|
| Sep 2023 | 1.22M | -550K | -45.05% |
| Dec 2023 | 1.08M | -1.09M | -101.48% |
| Mar 2024 | 1.26M | -853K | -67.38% |
| 2025 | 11.32M | -170.15K | -1.5% |
|---|---|---|---|
| 2026 | 16.48M | 4.02M | 24.43% |
| 2027 | 22.62M | 8.45M | 37.36% |
| 2028 | 29.43M | 13.32M | 45.28% |
Analysts Price target
Financials & Ratios estimates
| 2023-03-27 | 0.15 | -0.11 |
|---|
| Jun 2023 | 10497000 | 3.75M | 35.78% |
|---|---|---|---|
| Sep 2023 | 9947000 | 3.69M | 37.11% |
| Dec 2023 | 9955000 | 4.78M | 48.11% |
| Mar 2024 | 10385000 | 5.18M | 49.88% |
| Jun 2023 | -1.21M | 4.12M | -1K |
|---|---|---|---|
| Sep 2023 | -723K | 210K | 88K |
| Dec 2023 | -587K | -273K | 294K |
| Mar 2024 | -1.09M | -118K | 929K |
NEXGEL alternative data
| Aug 2023 | 12 |
|---|---|
| Sep 2023 | 12 |
| Oct 2023 | 12 |
| Nov 2023 | 12 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Mar 2024 | 12 |
| Apr 2024 | 12 |
| May 2024 | 19 |
| Jun 2024 | 19 |
| Jul 2024 | 19 |
NEXGEL other data
0.00%
-0.00%
of NXGL is owned by hedge funds
33.54K
-55.47K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 82939 | 0 |
| Aug 2024 | 50000 | 0 |
| Nov 2024 | 39316 | 0 |
| Dec 2024 | 0 | 3000 |
| Quarter | Transcript |
|---|---|
| Q1 2023 13 May 2024 | Q1 2023 Earnings Call Transcript |
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 17 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Adam R. Levy (1963) Chief Executive Officer, Pres & Director | $143,080 |
-
What's the price of NEXGEL stock today?
One share of NEXGEL stock can currently be purchased for approximately $2.39.
-
When is NEXGEL's next earnings date?
Unfortunately, NEXGEL's (NXGL) next earnings date is currently unknown.
-
Does NEXGEL pay dividends?
No, NEXGEL does not pay dividends.
-
How much money does NEXGEL make?
NEXGEL has a market capitalization of 31.71M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 99.66% to 4.09M US dollars. NEXGEL made a loss 3.16M US dollars in net income (profit) last year or -$0.11 on an earnings per share basis.
-
What is NEXGEL's stock symbol?
NEXGEL, Inc. is traded on the NASDAQ under the ticker symbol "NXGL".
-
What is NEXGEL's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of NEXGEL?
Shares of NEXGEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NEXGEL's key executives?
NEXGEL's management team includes the following people:
- Mr. Adam R. Levy Chief Executive Officer, Pres & Director(age: 62, pay: $143,080)
-
How many employees does NEXGEL have?
As Jul 2024, NEXGEL employs 19 workers, which is 58% more then previous quarter.
-
When NEXGEL went public?
NEXGEL, Inc. is publicly traded company for more then 3 years since IPO on 22 Dec 2021.
-
What is NEXGEL's official website?
The official website for NEXGEL is nexgel.com.
-
Where are NEXGEL's headquarters?
NEXGEL is headquartered at 2150 Cabot Boulevard West, Langhorne, PA.
-
How can i contact NEXGEL?
NEXGEL's mailing address is 2150 Cabot Boulevard West, Langhorne, PA and company can be reached via phone at 215 702 8550.
NEXGEL company profile:
NEXGEL, Inc.
nexgel.comExchange:
NASDAQ
Full time employees:
19
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
2150 Cabot Boulevard West
Langhorne, PA 19047
Langhorne, PA 19047
CIK: 0001468929
ISIN: US65344E1073
CUSIP: 65344E107
